Trial NCT02229149

View at ClinicalTrials.gov 
Org. Study IDs: 13011
Secondary IDs: ML29212

Last trial update was posted on 2022-12-02

MeSH Interventions

Capecitabine Docetaxel Paclitaxel Pertuzumab Trastuzumab Vinorelbine

MeSH Conditions

Breast Neoplasms

Other Conditions

Malignant Tumor of the Breast

Stopping Reasons

per Sponsor request

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID